Riskpilot← Back to searchSign inGet full accessPelago Bioscience AB
ABActiveOrg 5569241671Scheeles Väg 1Research and experimental development on natural sciences and engineering · NACE 7210Est. 201356 employees
Revenue 2024
SEK 96,1M
+10% vs 2023
EBITDA margin
-12.5%
-120% vs 2023
Equity ratio
58.0%
Financial strength
Net profit 2024
SEK -13,1M
-363% vs 2023
| Revenue | SEK 96,1M | +10% |
| EBITDA | SEK -12M | -120% |
| Net profit | SEK -13,1M | -363% |
| Total assets | SEK 86,4M | -6% |
| Equity | SEK 50,1M | -13% |
| Employees | 56 | — |
Legal name
Pelago Bioscience AB
Org number
5569241671
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
28 februari 2013
Share capital
SEK 119 000
Employees
56 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Gilham, Ian David i förening med Nordlund, Pär Lennart Steien, Lars Victor Harald Firman tecknas i förening av Dabrowski, Michael Adam Pedersen, Kia Anna Margaretha Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva uppdragsforskning för kunder inom bioteknik och läkemedelsutveckling, inklusive sådan verksamhet som har koppling till dessa tjänster, såsom IT-utveckling för att bearbeta datan framtagen genom uppdragsforskning. Bolaget ska även investera i och utveckla verksamheten i dotterbolag, ge ut licenser för användning av deras patenterade metoder, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Scheeles Väg 1
Email
contact@pelagobio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 34 720 | 43 078 | 62 799 | 73 838 | 82 790 | 87 583 | 96 099 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 225 | 2 063 | 3 001 | 6 462 | 7 675 | 12 803 | 14 031 | 10 898 | −5 456 | −12 021 |
| Depreciation & amort. | −158 | −372 | −528 | −2 282 | −3 379 | −3 241 | −4 003 | −5 109 | −3 670 | −5 316 |
| EBIT | 67 | 1 691 | 2 473 | 4 180 | 4 296 | 9 562 | 10 028 | 5 789 | −9 126 | −17 337 |
| Net financials | −38 | −33 | −44 | −155 | −98 | −42 | −16 | −90 | 2 046 | 894 |
| Profit before tax | 29 | 1 237 | 1 789 | 2 980 | 3 071 | 7 098 | 5 572 | 4 854 | 3 908 | −16 405 |
| Tax | −15 | −278 | −426 | −698 | −724 | −1 556 | −1 182 | −758 | 1 068 | 3 314 |
| Net profit | 14 | 959 | 1 363 | 2 282 | 2 347 | 5 542 | 4 390 | 4 096 | 4 976 | −13 091 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8 791 | 10 137 | 26 309 | 34 033 | 31 664 | 45 044 | 60 705 | 71 681 | 91 842 | 86 379 |
| Equity | 1 705 | 2 664 | 4 027 | 6 309 | 8 655 | 14 202 | 18 603 | 22 699 | 57 532 | 50 088 |
| Long-term debt | 500 | 469 | 2 959 | 3 013 | 2 055 | 0 | 0 | 94 | 94 | 0 |
| Short-term debt | 6 586 | 6 583 | 18 262 | 22 594 | 17 710 | 25 176 | 31 995 | 37 899 | 34 216 | 36 290 |
| Total debt | 7 086 | 7 052 | 21 221 | 25 607 | 19 765 | 25 176 | 31 995 | 37 993 | 34 310 | 36 290 |
EBITDA margin
-12.5%
This company
15.8%
Market median
-179% vs market
20152024
Equity ratio
58.0%
This company
38.2%
Market median
+52% vs market
20152024
Return on equity
-26.1%
This company
18.4%
Market median
-242% vs market
20152024
Net profit margin
-13.6%
This company
8.1%
Market median
-268% vs market
20152024
Asset turnover
1.11×
This company
1.12×
Market median
+1% vs market
20152024
Debt / equity
0.72×
This company
0.62×
Market median
+16% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KA Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AL Chief Auditor | Chief Auditor | 2024 | — | — |
MA Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
BS Audit | Audit | 2021 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2023 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pelago Bioscience AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kia Anna Margaretha Pedersen | Chief Executive Officer | 0 companies |
| Anna Linnea Franke | Chief Auditor | 0 companies |
| Michael Adam Dabrowski | Chief Executive Officer | 0 companies |
| Bo Sören Vik | Audit | 0 companies |
| Daniel Andreas Martinez Molina | Board of Directors | 0 companies |
| Anders Birger Nordström | Board of Directors | 0 companies |
| Mårten Winge | Board of Directors | 0 companies |
| Johan Lars Fredrik Lund | Board of Directors | 0 companies |
| Eirik Refstie | Board of Directors | 0 companies |
| Ian David Gilham | Chairman | 0 companies |
| Pär Lennart Nordlund | Board of Directors | 0 companies |
| Lars Victor Harald Steien | Board of Directors | 0 companies |
| Carl Magnus Edlund | Board of Directors | 0 companies |